These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects. Osborne MW, Wenger JJ, Willems W. J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901 [No Abstract] [Full Text] [Related]
3. [Cardiovascular effects of dimethophrine in the dog]. Monguzzi G, Romano A, Scrollini F. G Ital Cardiol; 1973 Sep; 3(1):102-11. PubMed ID: 4695015 [No Abstract] [Full Text] [Related]
4. Influence of phentolamine on the cardiovascular effects of dopamine in experimental cardiogenic shock. Bagwell EE, Daniell HB, Freeman BF. Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):197-203. PubMed ID: 4852444 [No Abstract] [Full Text] [Related]
5. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs]. Urbaszek W, Günther K, Trenckmann H, Döring D. Z Gesamte Inn Med; 1970 Apr 01; 25(7):290-3. PubMed ID: 4398843 [No Abstract] [Full Text] [Related]
6. [Cardio-vascular effects of L-dopa]. Warembourg H, Ducloux G, Mouton Y, Warot P. Coeur Med Interne; 1972 Apr 01; 11(3):439-49. PubMed ID: 4636688 [No Abstract] [Full Text] [Related]
7. [Cardiovascular effects of glucagon]. Lavarenne J. Therapie; 1974 Apr 01; 29(2):161-84. PubMed ID: 4368071 [No Abstract] [Full Text] [Related]
13. Effect of camazepam (SB-5833), a new antianxious drug, on cardiac contractility and coronary hemodynamics. Merlo L, Noseda V, Ferrini R, Miragoli G, Marchetti G. Arzneimittelforschung; 1974 Nov 01; 24(11):1759-62. PubMed ID: 4155634 [No Abstract] [Full Text] [Related]
14. Effects of oleandrin on cardiovascular hemodynamics in the dog. Deavers SI, Rosborough JP, Hoff HE, McCrady JD. Am J Vet Res; 1979 Oct 01; 40(10):1421-5. PubMed ID: 575023 [No Abstract] [Full Text] [Related]
15. Cardiohemodynamic actions of nitroglycerin and diltiazem in canine coronary stenosis. Futamura Y, Nomura H, Nagata K, Hama Y, Yasui S. Arzneimittelforschung; 1982 Oct 01; 32(1):34-9. PubMed ID: 6800385 [No Abstract] [Full Text] [Related]
16. Cardiovascular effects of glucagon following cardiac surgery. Vaughn CC, Warner HR, Nelson RM. Surgery; 1970 Jan 01; 67(1):204-11. PubMed ID: 5409857 [No Abstract] [Full Text] [Related]
17. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa]. Pletscher A, Bartholini G, Gey KF, Jenni A. Schweiz Med Wochenschr; 1970 May 09; 100(19):797-804. PubMed ID: 4924275 [No Abstract] [Full Text] [Related]
18. Cardiovascular effects of glucagon in man. Klein SW, Morch JE, Mahon WA. Can Med Assoc J; 1968 Jun 22; 98(25):1161-4. PubMed ID: 5657181 [No Abstract] [Full Text] [Related]
19. Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405). Caravaggi AM, Sardi A, Baldoli E, Di Francesco GF, Luca TC. Arch Int Pharmacodyn Ther; 1977 Mar 22; 226(1):139-48. PubMed ID: 869636 [Abstract] [Full Text] [Related]
20. [Cardiovascular effects of trazodone in humans. Study of 10 patients]. Allaria B, Favaro M, Arienta R, Dei Poli M, Trivellato A, Brioschi F. Minerva Anestesiol; 1983 Mar 22; 49(1-2):1-6. PubMed ID: 6835524 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]